The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Aimbig, a lot of the larger buys that c7 mentioned were executed/printed just after the closing bell so the majority of the commentary was after hours (as were the trades). N the same note you suggest such trades are designed to get an upward movement.
Not sure how after hour trades are able to move the intraday share price ? Maybe you could elaborate on your many theories ?
With the EMA now saying that regular booster shots won’t work, scancells interim covid results due out shortly in which they state should last for ‘SEVERAL YEARS’ couldn’t come at a better time.
https://www.bloombergquint.com/onweb/repeat-booster-shots-risk-overloading-immune-system-ema-says
https://www.ft.com/content/49641651-e10a-45f6-a7cc-8b8c7b7a9710
If the results come even close to what scancell say it can do then the share price will absolutely explode and would expect immunobody platform to be bought out by a major pharmaceutical company within months if not weeks after the results and wouldn’t be surprised to see a bidding war on it !
Excellent post and I don’t remember seeing this bit before
“A vaccine encoding both nucleocapsid protein linked to a modified Fc and receptor-binding domain should stimulate long-term memory B and T cells, and should give sustained protection over several years. This will give less opportunities for variants to arise and prevent people from having to be vaccinated every six months.”